Trial
NCT07108140
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
TCRCure Biopharma Ltd.
Collaborators
Nanjing University School of Medicine
Condition
Solid Tumor
Intervention
Anti ALPP CAR-T cells treatment
Why stopped
Portfolio prioritization
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-22